These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33987362)

  • 1. LncRNA ABCC6P1 promotes proliferation and migration of papillary thyroid cancer cells via Wnt/β-catenin signaling pathway.
    Guan Y; Li Y; Yang QB; Yu J; Qiao H
    Ann Transl Med; 2021 Apr; 9(8):664. PubMed ID: 33987362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
    Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA FALEC promotes proliferation, migration, and invasion of PTC cells through regulating Wnt/β-catenin signaling pathway.
    Xiao X; Li L; Cui JC; Wang Y
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4361-4367. PubMed ID: 32373973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
    Xia S; Ji R; Zhan W
    BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway.
    Lv P; Xue Y
    Bioengineered; 2021 Dec; 12(1):3873-3885. PubMed ID: 34281460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
    Zhou Z; Liu Y; Ma M; Chang L
    Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-200c promotes proliferation of papillary thyroid cancer cells via Wnt/β-catenin signaling pathway.
    Ren ZF; Du MF; Fu H; Liu J; Xia FY; Du HN; Liu N
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5512-5518. PubMed ID: 32495886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of LINC0163 promotes progression of papillary thyroid cancer by regulating epithelial-mesenchymal transition MITF.
    Gao P; Jiao H; Zhe L; Cui J
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5504-5511. PubMed ID: 32495885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathway.
    Zhong J; Lin R; Wang G; Lin L; Ruan S; Liu W
    Tissue Cell; 2022 Apr; 75():101739. PubMed ID: 35066335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANKRD22 knockdown suppresses papillary thyroid cell carcinoma growth and migration and modulates the Wnt/β-catenin signaling pathway.
    Wu Y; Chen W; Zhang B; Liu H
    Tissue Cell; 2023 Oct; 84():102193. PubMed ID: 37586180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
    Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
    Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling.
    Wang X; Lu X; Geng Z; Yang G; Shi Y
    J Cell Biochem; 2017 Dec; 118(12):4745-4752. PubMed ID: 28513866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT1-induced upregulation of lncRNA LINP1 promotes cell proliferation and inhibits apoptosis via AMPK signaling pathway in papillary thyroid cancer.
    Li HP; Yang TZ; Wei L; Ge YF; Meng QS
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8911-8917. PubMed ID: 32964981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-3619-3p promotes papillary thyroid carcinoma progression via Wnt/β-catenin pathway.
    Yu S; Cao S; Hong S; Lin X; Guan H; Chen S; Zhang Q; Lv W; Li Y; Xiao H
    Ann Transl Med; 2019 Nov; 7(22):643. PubMed ID: 31930044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXN3 suppresses the growth and invasion of papillary thyroid cancer through the inactivation of Wnt/β-catenin pathway.
    Zhao C; Mo L; Li C; Han S; Zhao W; Liu L
    Mol Cell Endocrinol; 2020 Sep; 515():110925. PubMed ID: 32619584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA ROR1‑AS1 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/β-catenin/EMT signaling cascade in cervical cancer.
    Zhang L; Yao HR; Liu SK; Song LL
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2928-2937. PubMed ID: 32271410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA CRNDE is activated by SP1 and promotes osteosarcoma proliferation, invasion, and epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway.
    Ding Q; Mo F; Cai X; Zhang W; Wang J; Yang S; Liu X
    J Cell Biochem; 2020 Jun; 121(5-6):3358-3371. PubMed ID: 31898343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LEM domain containing 1 promotes thyroid cancer cell proliferation and migration by activating the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
    Xu M; Lin B; Zheng D; Wen J; Hu W; Li C; Zhang X; Zhang X; Qu J
    Oncol Lett; 2021 Jun; 21(6):442. PubMed ID: 33868480
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Liang WQ; Zeng D; Chen CF; Sun SM; Lu XF; Peng CY; Lin HY
    Cancer Manag Res; 2019; 11():2059-2072. PubMed ID: 30881130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
    Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J
    J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.